NanoViricides Inc. (NNVC)

[changes_iv]

If drunk, don't drive. That is good advice.

Did you tout FluDase as Flucide(TM) competition?

NexBio...
-A small-biotech that is privately-held
-with Fludase a first-in-class Influenza drug
-government begins to grease skids for the small-biotech, Aug 8, 2005?
-a 50m contract with the NIH, fast-tracked

Why would a privately-held company, that seems to have everything going for them, would feel the urge to defraud the United States of America/taxpayers funded NIH? Cash-flow problems? with a 50m biologic-contract, how can that be?

Since its founding in 2003, NexBio has received at least $73 million in grants and contracts from the National Institutes of Health to develop and test Fludase, according to agency records and a 2009 report from the San Diego industry group Biocom.

After operating solely with government funding, the company in recent years tried to raise money from investors. It isn't clear whether those efforts were successful.

Company officials did not respond to several telephone and email messages.

source: http://www.sandiegouniontribune.com/news/2011/aug/04/feds-raid-san-diego-vaccine-developer/

=============================================

"I suppose" the "con blogger", "Pump Terminator", could soon be coming out of his closet to reiterate everything he has blogged about our small company in the past, plus an update on why he/she/they believe the risk has jumped from 80% to 99%. "I must confess", I feel pretty confident the sociopath/white-collar criminal will not be outdoing himself and instead rely solely on minimum wage cons/alias/anonymous posters.

Recent “Bear” Attack

As many of you know, a malicious and possibly criminal attack on our common stock was carried out on February 11, 2014, through the publication of a false and misleading article on Seeking Alpha. The intent of the article was to dramatically drive down our stock price. The article resulted in a highly increased daily trading volume of eight million shares, approximately 20 times our daily average. The information we have gathered suggests that this was an organized attack using false and inaccurate information designed to benefit short sellers in the stock. We have reported this conduct to the regulatory authorities and have retained legal counsel to investigate both the website that hosted this article and the anonymous blogger who authored it.

www.nanoviricides.com/2014-ceo-letter.pdf